Summer Clinical Practice Test

Session length

1 / 20

A patient with COPD on supplemental oxygen has SpO2 of 92%. What does this indicate about oxygenation goals?

SpO2 within the typical COPD target range (88–92%), adjust per orders.

In COPD, oxygen targets are kept a bit lower to avoid unintentionally suppressing the drive to breathe while still preventing hypoxemia. The commonly used goal is to maintain SpO2 in the 88–92% range. If a patient on supplemental oxygen has an SpO2 of 92%, that sits at the upper end of this target and indicates the current oxygenation goal is being met within the COPD-specific range. It’s not necessary to push toward normal 96–98% in this setting, because that could increase the risk of CO2 retention and hyperoxia-related complications. The reading shows oxygenation status as intended by COPD management guidelines, and you would continue the current oxygen therapy unless orders specify a different target.

SpO2 should be increased to 96–98%.

Indicates hyperoxia.

Cannot determine oxygenation status.

Next question

Find the option that is right for you!

All options are one-time payments.

$12.50

30 day premium pass

All the basics to get you started

  • Ad-free experience
  • View your previous attempt history
  • Mobile app access
  • In-depth explanations
  • 30 day premium pass access
👑$30.00 $87.50 usd

6 month DELUXE pass (most popular)

Everything with the 30 day premium pass FOR 6 MONTHS! & the ultimate digital PDF study guide (BONUS)

  • Everything included in the premium pass
  • $87.50 usd value for $30.00! You save $57.50!
  • + Access to the ultimate digital PDF study guide
  • + 6 months of premium pass access
  • + Priority support
$12.50 $18.99

Ultimate digital PDF study guide

For those that prefer a more traditional form of learning

  • Available for instant download
  • Available offline
  • Hundreds of practice multiple choice questions
  • Comprehensive content
  • Detailed explanations
Image Description
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy